Italian researchers discovered two new cannabinoids within Cannabis sativa, tetrahydrocannabiphorol (THCP) and cannabidiphorol (CBDP). Scientists in Italy used a mass spectrometer to isolate atoms and identify compounds within cannabis plants. The two cannabinoids and its unique properties when consumed are still unknown. One of the theories behind the first cannabinoid, THCP, is that its presence provides for variability in the effects between different cannabis plant strains. It is possible to find over 400 chemicals in Cannabis sativa and tetrahydrocannabinol (THC), the most known chemical that provides the psychoactive “high” associated with cannabis, was outnumbered by THCP in lower doses. CBDP amounts associated within the study performed on mice was low as well and is attributed to the quality of the low-THC cannabis, cannabis named FM2, that is grown by the military in Italy.
In 2019, the scientists who made the discovery of THCP and CBDP announced the discovery of CBDB and THCB. It was reported by the researchers that THCB appeared to provide pain relief in mice and the next step for the team is to continue the investigation into the anti-convulsive and anti-inflammatory properties of CBDP. The status of both CBDB and THCB is also believed to be not as well-known as could be as it is still relatively new. All four recently discovered cannabinoids could be the next step in specifically targeted aspects in use with cannabis. It would be entirely possible to cultivate a strain of cannabis to be primarily dominant in THCB in order to create a dried cannabis flower product or other cannabis-infused derivative that is strong in pain relief properties.
Curious about how you can make money investing in cannabis? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.